Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonja N Brun

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|November 21, 2018
Autophagy in Cancer: Regulation by Small MoleculesAllison S Limpert, Lester J Lambert, Nicole A Bakas, et al.
Genes & Development|January 28, 2009
N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastomaJessica D Kessler, Hiroshi Hasegawa, Sonja N Brun, et al.
Development (Cambridge, England)|March 31, 2012
WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellumYanxin Pei, Sonja N Brun, Shirley L Markant, et al.
Science Advances|March 17, 2023
HDAC3 is critical in tumor development and therapeutic resistance in <i>Kras</i>-mutant non-small cell lung cancerLillian J Eichner, Stephanie D Curtis, Sonja N Brun, et al.
Science Advances|April 8, 2021
AMPK/ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagyChien-Min Hung, Portia S Lombardo, Nazma Malik, et al.
Oncogene|February 3, 2021
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signalingChenchu Lin, Alicia M Blessing, Thomas L Pulliam, et al.
Cell Metabolism|November 13, 2018
Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer ModelsLillian J Eichner, Sonja N Brun, Sébastien Herzig, et al.
Journal of Medicinal Chemistry|November 17, 2020
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast CancerHuiyu Ren, Nicole A Bakas, Mitchell Vamos, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant CancersPatrick M Hagan, Huiyu Ren, Sonja N Brun, et al.
Cancer Discovery|July 28, 2019
The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLCPablo E Hollstein, Lillian J Eichner, Sonja N Brun, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|November 21, 2018
Autophagy in Cancer: Regulation by Small MoleculesAllison S Limpert, Lester J Lambert, Nicole A Bakas, et al.
Genes & Development|January 28, 2009
N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastomaJessica D Kessler, Hiroshi Hasegawa, Sonja N Brun, et al.
Development (Cambridge, England)|March 31, 2012
WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellumYanxin Pei, Sonja N Brun, Shirley L Markant, et al.
Science Advances|March 17, 2023
HDAC3 is critical in tumor development and therapeutic resistance in <i>Kras</i>-mutant non-small cell lung cancerLillian J Eichner, Stephanie D Curtis, Sonja N Brun, et al.
Science Advances|April 8, 2021
AMPK/ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagyChien-Min Hung, Portia S Lombardo, Nazma Malik, et al.
Oncogene|February 3, 2021
Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signalingChenchu Lin, Alicia M Blessing, Thomas L Pulliam, et al.
Cell Metabolism|November 13, 2018
Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer ModelsLillian J Eichner, Sonja N Brun, Sébastien Herzig, et al.
Journal of Medicinal Chemistry|November 17, 2020
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast CancerHuiyu Ren, Nicole A Bakas, Mitchell Vamos, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant CancersPatrick M Hagan, Huiyu Ren, Sonja N Brun, et al.
Cancer Discovery|July 28, 2019
The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLCPablo E Hollstein, Lillian J Eichner, Sonja N Brun, et al.
Pageof 2